A timely assessment of response to treatment in type 2 diabetic (T2DM) patients initiating a pharmacological treatment could be useful for avoiding longer-term use of ineffective drugs. HbA1c, which is correlated with average glucose of the previous 3–4 months [1], is currently considered the gold standard for monitoring glucose control. Effects of variations of treatment are usually assessed through HbA1c determination after 3 or more months. Shorter-term variations of HbA1c could theoretically predict longer-term variations of the same variable. Glycated albumin (GA) has been proposed as an indicator of shorter-term (2-week) glucose control [2], although standardization of measurement methods has not been achieved yet [3]. The aim of the present pilot study was to explore the possibility of predicting 3-month HbA1c variation by measuring HbA1c or GA at 15 and 30 days.
Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes? / Luconi, Michaela; Nreu, Besmir; Samavat, Jinous; Lorubbio, Maria; Ognibene, Agostino; Monami, Matteo; Mannucci, Edoardo. - In: ACTA DIABETOLOGICA. - ISSN 1432-5233. - STAMPA. - 53:(2016), pp. 669-672. [10.1007/s00592-015-0809-x]
Is early measurement of glycated albumin and HbA1c useful for the prediction of treatment response in type 2 diabetes?
LUCONI, MICHAELA
;NREU, BESMIR;LORUBBIO, MARIA;MANNUCCI, EDOARDO
2016
Abstract
A timely assessment of response to treatment in type 2 diabetic (T2DM) patients initiating a pharmacological treatment could be useful for avoiding longer-term use of ineffective drugs. HbA1c, which is correlated with average glucose of the previous 3–4 months [1], is currently considered the gold standard for monitoring glucose control. Effects of variations of treatment are usually assessed through HbA1c determination after 3 or more months. Shorter-term variations of HbA1c could theoretically predict longer-term variations of the same variable. Glycated albumin (GA) has been proposed as an indicator of shorter-term (2-week) glucose control [2], although standardization of measurement methods has not been achieved yet [3]. The aim of the present pilot study was to explore the possibility of predicting 3-month HbA1c variation by measuring HbA1c or GA at 15 and 30 days.File | Dimensione | Formato | |
---|---|---|---|
Luconi et al acta diab 2016.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
616.92 kB
Formato
Adobe PDF
|
616.92 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.